News

A new study has found the prevalence of multiple sclerosis rose by a third between 2006 and 2022. The University of Auckland study used Stats NZ data and included anonymous data from hospitalisations, ...
New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies.
Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...
Neural stem cell treatment was safe and significantly boosted myelin repair in spinal cord lesions in a mouse model of MS, ...
The rates of people MS advancing from RRMS to SPMS have decreased significantly in the past decades, according to a 30-year ...
The University of Cincinnati joins a Phase 1 clinical trial testing CAR-T cell therapy for MS, exploring this cancer ...
Panelists discuss how emerging biomarkers like neurofilament light protein, glial fibrillary acidic protein (GFAP), cervical cord atrophy, and phase rim lesions could enable earlier identification of ...
Wayne Dobson, the magician, who has died aged 68, drew an audience of 11 million bamboozled viewers for his ITV series A Kind ...
Multiple Sclerosis (MS) is a lifelong problem, and as patients age, MS often changes from a manageable condition to something ...
Multiple sclerosis (MS) is an immune-mediated inflammatory disease characterized by demyelination and degeneration in the ...
Vaccination against COVID-19 is crucial for individuals with multiple sclerosis (MS), ensuring safety and effectiveness despite immunosuppressive therapies.